Las dos primeras páginas del informe (Indice e Introducción) no llevarán. El informe se entregará en soporte digital y papel del I.A.P.H. Fulgent was founded in 2011 and is based in Temple City, California. El tiempo y el presupuesto para la elaboración del INFORME DIAGNÓSTICO, el PROYECTO DE INTERVENCIÓN y la MEMORIA FINAL DE INTERVENCIÓN irán en función de las características de la obra. A cornerstone of the Company’s business is its ability to provide expansive options and flexibility for all clients’ unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service, and automated lab services. Combining next-generation sequencing with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. Fulgent’s proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy, and competitive turnaround times. There are 6 companies in the Inform Diagnostics corporate family. Inform Diagnostics has 1 employees at this location. “We expect to see an immediate contribution from Inform Diagnostics’ mature pathology business, while in the longer term we also believe there are numerous synergies across our organizations that will drive sustained momentum across Fulgent’s core testing business,” Hsieh said.Fulgent is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Company Description: Inform Diagnostics is located in Phoenix, AZ, United States and is part of the Medical and Diagnostic Laboratories Industry. Fulgent also expects to offer NGS-based oncology services to Inform Diagnostics’ hematology clients. It also extends Fulgent’s in-network managed care relationships to over 300 million covered lives as well as adds CLIA-, CAP-, and NY State-certified laboratories in Irving, Boston, New York City, and Phoenix.įulgent said it can now leverage Inform’s “nationwide client base, established commercial organization, and managed care relationships” to expand the reach of its existing services, including a menu of customizable genomic tests for more than 18,400 genes.įulgent highlighted cross-selling opportunities with Inform Diagnostics’ national gastrointestinal and genitourinary specialist client base, including for Fulgent’s newly launched liquid biopsy test for hepatocellular carcinoma, HelioLiver, as well as for an upcoming molecular test for urology. The acquisition expands Fulgent’s test menu into breast pathology, gastrointestinal pathology, dermatopathology, urologic pathology, neuropathology, and hematopathology, the firm said. “We have been impressed with the Inform Diagnostics team’s commitment to quality, turnaround time, and customer service, which we believe fits well with our priorities, culture, and focus at Fulgent,” Ming Hsieh, chairman and CEO of Fulgent, said in a statement. It is a portfolio company of Avista Capital Partners based in Irving, Texas. Inform Diagnostics currently provides pathology services to approximately 1,300 clients who represent over 2,700 physicians. On average, analysts are estimating first quarter revenues of $244.7 million. This exceeds prior guidance of $245 million and includes $22 million of core revenues excluding next-generation sequencing (NGS)-based COVID-19 testing. The firm also announced that it will acquire pathology laboratory Inform Diagnostics for $170 million in cash.įulgent’s revenues for the quarter ended March 31, 2022, are expected to be approximately $300 million. NEW YORK – Fulgent Genetics reported on Monday estimated preliminary first quarter revenues above prior guidance.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |